Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W. Tseng, Alessandro Gronchi, Markus Albertsmeier et al.|Cancer|2020Cited by 48
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional TARPSWG study.William W. Tseng, Francesco Barretta, Lorenzo Conti et al.|Journal of Clinical Oncology|2020Cited by 3
Abstract 2012: Recurrent rearrangements of NAALADL2 in prostate, breast, cervical, head and neck and lung squamous cell carcinomaPavithra D. Arachchige, Nallasivam Palanisamy, Shannon Carskadon et al.|Cancer Research|2020Cited by 2